Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01526681 · ClinicalTrials.gov registry record
Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
A clinical trial of Peripheral Nerve Injuries, sponsored by Axogen Corporation.
- Active
- Registry status
- 3,126
- Enrollment target
- 20
- Study locations
NCT01526681 is a study of Peripheral Nerve Injuries that is active but no longer recruiting, run by Axogen Corporation. The registered enrollment target is 3,126 participants, above the 71-participant average among 8 other Peripheral Nerve Injuries trials with a reported enrollment target (4303% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT01526681, a study of Peripheral Nerve Injuries, is active but no longer recruiting, sponsored by Axogen Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- 3,126 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is a registry of general use of Avance Nerve Graft and is intended to evaluate the uses, response rates, and safety of Avance Nerve Graft in the real-life clinical setting. Optional addendums 1 and 2 included in the protocol are intended to establish comparative groups and focused subgroups within the registry.
Conditions Studied
Interventions
- OTHER Processed Human Nerve Graft
- OTHER Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.
- OTHER Autogenous Nerve Graft
- DEVICE Nerve Tube Conduit
- PROCEDURE Autologous Breast Reconstruction with Neurotization
Study Locations (20)
California
- RANGER & MATCH: University of California - Irvine - Orange
- RANGER & MATCH: The Buncke Clinic - San Francisco
- Sensation-NOW: Stanford University - Stanford
Maryland
- RANGER: Johns Hopkins University - Baltimore
- Sensation-NOW: Johns Hopkins University - Baltimore
- RANGER: Walter Reed National Military Medical Center - Bethesda
Arizona
- RANGER & MATCH: Arizona Center for Hand Surgery - Phoenix
- RANGER: Phoenix Children's Hospital - Phoenix
Florida
- RANGER: University of Miami - Miami
- RANGER & MATCH: Florida Orthopaedic Institute - Tampa
Kansas
- RANGER & MATCH: University of Kansas Medical Center - Kansas City
- Sensation-NOW: University of Kansas Medical Center - Kansas City
Colorado
- Sensation-NOW: University of Colorado School of Medicine - Aurora
District of Columbia
- Sensation-NOW: George Washington University - Washington D.C.
Georgia
- RANGER: Hand & Upper Extremity Center of Georgia/Children's Hospital of Atlanta - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,126 participants |
| Start Date | 2008-11 |
| Est. Completion | 2028-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01526681
The ClinicalTrials.gov registry entry for NCT01526681 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 3,126 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 71-participant average among 8 other Peripheral Nerve Injuries trials with a reported enrollment target (4303% higher). The listed sponsor is Axogen Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Nerve Injuries appearing as the primary indexed condition, and to 5 interventions - of which Processed Human Nerve Graft is the first listed.
NCT01526681 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Maryland, Arizona.
Frequently Asked Questions
What is clinical trial NCT01526681 about?
NCT01526681 is a clinical study titled "Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction". This study is a registry of general use of Avance Nerve Graft and is intended to evaluate the uses, response rates, and safety of Avance Nerve Graft in the real-life clinical setting. Optional addendums 1 and 2 included in the protocol are intended to establish comparative groups and focused subgrou...
What is the current status of trial NCT01526681?
This trial is currently active not recruiting. The enrollment target is 3,126 participants. The study started on 2008-11. Estimated completion is 2028-11.
What conditions does trial NCT01526681 study?
This clinical trial studies the following conditions: Peripheral Nerve Injuries.
What interventions are being tested in trial NCT01526681?
The interventions under investigation include: Processed Human Nerve Graft (OTHER), Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc. (OTHER), Autogenous Nerve Graft (OTHER), Nerve Tube Conduit (DEVICE), Autologous Breast Reconstruction with Neurotization (PROCEDURE).
Who is sponsoring clinical trial NCT01526681?
This trial is sponsored by Axogen Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01526681 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Nerve Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
RECRUITING · NA
-
Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)
RECRUITING · Phase 2
-
Promoting Healing of Injured Nerves With Electrical Stimulation Therapy
RECRUITING · NA
-
Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)
RECRUITING · NA
-
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
RECRUITING · Phase 2
-
A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.